DDC-29629-74187
3 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 805 / CO
- Registered
- 2022-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-01
Dose 1 — Pfizer-BioNTech
-
2021-02-02
Dose 2 — Pfizer-BioNTech
-
2022-01-02
Registered in v-safe
-
2022-01-02
Dose 3 — Pfizer-BioNTech
-
2022-01-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-01-04
- 2022-01-05
- 2022-01-06
- 2022-01-07
- 2022-01-08
- 2022-01-09
-
2022-01-16
Survey response — day 14, dose 3MedDRA: Breast feeding, Menstruation irregular, Postpartum haemorrhage — Feeling: GoodFree text: Started my period at 9weeks post partum despite full time on demand breastfeeding of full term healthy infant.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-01 | Pfizer-BioNTech | No |
| 2 | 2021-02-02 | Pfizer-BioNTech | No |
| 3 | 2022-01-02 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 3
Symptoms: Started my period at 9weeks post partum despite full time on demand breastfeeding of full term healthy infant.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breast feeding | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Postpartum haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release